Our Visitors
IP Watch Dog
U.S. Government Sides with Teva in Skinny Label SCOTUS FightThe U.S. Solicitor General on Wednesday filed an amicus brief with the United States Supreme Court advising it to grant Teva Pharmaceuticals’ petition for writ of certiorari relating to generic manufacturers’ liability for infringement through the use of “skinny labels” on generic drugs. The SG’s brief said that the U.S. Court of Appeals for the…
Recovering Fees and Expenses For U.S. Discovery Compliance in Foreign Litigation – Improbable Even When PossibleUnder 28 U.S.C. Section 1782, parties engaged in (or expected to engage in) foreign litigation are empowered to seek discovery in the United States for use in the foreign litigation. Specifically, under § 1782, foreign litigants may apply directly to any district court in the U.S. where a person or entity with information relevant to the foreign…
Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC HearingThe International Trade Commission (ITC) conducted an all-day hearing today featuring a range of stakeholders with interests in the World Trade Organization’s (WTO) pending decision on extending what has come to be known as the TRIPS [Agreement on Trade-Related Aspects of Intellectual Property Rights] waiver from strictly COVID-19 vaccine technologies to COVID-19 related therapeutics and…